| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.2M | -73.1% | -80.2% |
| Cost of Revenue | $14.7M | -27.2% | +21.6% |
| R&D Expense | $121.1M | -5.9% | +62.3% |
| SG&A Expense | $41.6M | -10.8% | +10.3% |
| Operating Income | -$172.2M | +2.3% | -75.1% |
| Pre-tax Income | -$162.3M | +5.6% | -69.6% |
| Income Tax | $3K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $659.8M | +25.7% | +54.3% |
| Current Assets | $714.1M | +21.6% | +50.6% |
| Total Assets | $1.40B | +7.5% | +92.6% |
| Current Liabilities | $155.1M | -5.4% | +42.4% |
| Long-term Debt | $11.9M | -16.2% | -42.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$325.7M | — | — |
| Capital Expenditures | $5.2M | — | — |
| Investing Cash Flow | -$15.6M | — | — |
| Financing Cash Flow | $389.5M | — | — |
| Free Cash Flow | -$331.0M | — | — |
| — |
| -98.2% |
| Net Income | -$162.3M | +5.6% | -69.3% |
| EPS (Basic) | -$0.36 | +12.2% | -5.9% |
| EPS (Diluted) | -$0.36 | +12.2% | -5.9% |
| $352.6M |
| -8.0% |
| +74.6% |
| Stockholders' Equity | $1.05B | +13.9% | +99.6% |